AU4436989A - One-step immunoassay for determining antigen-specific antibodies of all immunoglobulin classes, and an agent therefor - Google Patents

One-step immunoassay for determining antigen-specific antibodies of all immunoglobulin classes, and an agent therefor

Info

Publication number
AU4436989A
AU4436989A AU44369/89A AU4436989A AU4436989A AU 4436989 A AU4436989 A AU 4436989A AU 44369/89 A AU44369/89 A AU 44369/89A AU 4436989 A AU4436989 A AU 4436989A AU 4436989 A AU4436989 A AU 4436989A
Authority
AU
Australia
Prior art keywords
specific antibodies
step immunoassay
immunoglobulin classes
antigen
agent therefor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU44369/89A
Other versions
AU624650B2 (en
Inventor
Udo Krupka
Hans-Erwin Pauly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Dade Behring Marburg GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6366574&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU4436989(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dade Behring Marburg GmbH filed Critical Dade Behring Marburg GmbH
Publication of AU4436989A publication Critical patent/AU4436989A/en
Application granted granted Critical
Publication of AU624650B2 publication Critical patent/AU624650B2/en
Assigned to DADE BEHRING MARBURG GMBH reassignment DADE BEHRING MARBURG GMBH Request to Amend Deed and Register Assignors: BEHRINGWERKE AKTIENGESELLSCHAFT
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • G01N33/5764—Hepatitis B surface antigen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • G01N33/5762—Hepatitis B core antigen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
    • G06V10/00—Arrangements for image or video recognition or understanding
    • G06V10/70—Arrangements for image or video recognition or understanding using pattern recognition or machine learning
    • G06V10/77—Processing image or video features in feature spaces; using data integration or data reduction, e.g. principal component analysis [PCA] or independent component analysis [ICA] or self-organising maps [SOM]; Blind source separation
    • G06V10/80—Fusion, i.e. combining data from various sources at the sensor level, preprocessing level, feature extraction level or classification level
    • G06V10/806—Fusion, i.e. combining data from various sources at the sensor level, preprocessing level, feature extraction level or classification level of extracted features

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Virology (AREA)
  • Theoretical Computer Science (AREA)
  • Artificial Intelligence (AREA)
  • Multimedia (AREA)
  • Software Systems (AREA)
  • Evolutionary Computation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Computing Systems (AREA)
  • Medical Informatics (AREA)
  • AIDS & HIV (AREA)
  • Databases & Information Systems (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

A process for preparing an agent with which a one-step immunoassay can be carried out for determining antigen-specific antibodies of all immunoglobulin classes is described. In the one-step immunoassay, carrier-bound antigen (solid phase) and dissolved labelled antigen of the same specificity are incubated, in a ratio determined in the preparation process, at the same time with the antibody-containing liquid sample. The liquid phase is separated from the solid phase and then the labelling on the solid phase is determined.
AU44369/89A 1988-11-05 1989-11-03 One-step immunoassay for determining antigen-specific antibodies of all immunoglobulin classes, and an agent therefor Expired AU624650B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3837616 1988-11-04
DE3837616A DE3837616A1 (en) 1988-11-05 1988-11-05 ONE-STEP IMMUNITY TEST FOR DETERMINING ANTIGEN-SPECIFIC ANTIBODIES OF ALL IMMUNOGLOBULIN CLASSES AND MEANS THAT ARE SUITABLE FOR THIS

Publications (2)

Publication Number Publication Date
AU4436989A true AU4436989A (en) 1990-05-10
AU624650B2 AU624650B2 (en) 1992-06-18

Family

ID=6366574

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44369/89A Expired AU624650B2 (en) 1988-11-05 1989-11-03 One-step immunoassay for determining antigen-specific antibodies of all immunoglobulin classes, and an agent therefor

Country Status (7)

Country Link
EP (1) EP0372217B1 (en)
JP (1) JP2972241B2 (en)
AT (1) ATE122150T1 (en)
AU (1) AU624650B2 (en)
CA (1) CA2002220A1 (en)
DE (2) DE3837616A1 (en)
ES (1) ES2072883T3 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI90800C (en) * 1991-03-13 1994-03-25 Veikko Naentoe Biospecific assay method and product for assay
CA2064953A1 (en) * 1991-04-03 1992-10-04 John Joseph Rejman Immunoassay for immunoglobulins
AT400640B (en) * 1994-04-26 1996-02-26 Waldheim Pharmazeutika Gmbh METHOD FOR DETECTING AN ANTIBODY
CN1300587C (en) * 2004-12-20 2007-02-14 山东省医药生物技术研究中心 Protein chip for detecting blood and cerebro spinal fluid pathogen antibody, and its preparing method and use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016043A (en) * 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
EP0146654A3 (en) * 1980-06-20 1986-08-20 Unilever Plc Processes and apparatus for carrying out specific binding assays
ES8307897A1 (en) * 1981-04-13 1983-08-01 Hoechst Co American Single incubation immunochemical assay for creatin phosphokinase MB.
US4595661A (en) * 1983-11-18 1986-06-17 Beckman Instruments, Inc. Immunoassays and kits for use therein which include low affinity antibodies for reducing the hook effect
NZ212546A (en) * 1984-07-16 1988-09-29 Abbott Lab Immunoassay for detecting antibody to hepatitis b surface antigen/a
NZ222465A (en) * 1986-11-07 1992-11-25 Pasteur Institut Nanb (non a, non b hepatitis viral) antigen
GB8707839D0 (en) * 1987-04-02 1987-05-07 Secr Social Service Brit Immunoglobulin assay method
DE3717401A1 (en) * 1987-05-23 1988-12-08 Behringwerke Ag One-step immunoassay for the determination of antigen-specific antibodies from one of the immunoglobulin classes A, M, D or E and a suitable agent

Also Published As

Publication number Publication date
CA2002220A1 (en) 1990-05-05
EP0372217B1 (en) 1995-05-03
ES2072883T3 (en) 1995-08-01
ATE122150T1 (en) 1995-05-15
AU624650B2 (en) 1992-06-18
DE58909219D1 (en) 1995-06-08
EP0372217A2 (en) 1990-06-13
JP2972241B2 (en) 1999-11-08
EP0372217A3 (en) 1991-10-23
JPH02171655A (en) 1990-07-03
DE3837616A1 (en) 1990-05-10

Similar Documents

Publication Publication Date Title
AU532303B2 (en) Determination of immuno-complexes in liquids
AU591667B2 (en) Delayed solid phase immunologic assay
GR850899B (en)
JPS6428560A (en) Immunometric measurement
CA2113383A1 (en) Immunometric determination of an antigen or hapten
AU566742B2 (en) Immunologic latex agglutination process
ES8503855A1 (en) Homogeneous immunoassay with labelled monoclonal anti-analyte.
AU561056B2 (en) Immunoassay for free throxine in plasma, serum or whole blood
AU4436989A (en) One-step immunoassay for determining antigen-specific antibodies of all immunoglobulin classes, and an agent therefor
AU618137B2 (en) Process for the determination of antibodies which are class-specific for an antigen and a reagent for carrying out the process
AU657719B2 (en) Methods for determination of an analyte
AU635243B2 (en) Immunoassay of human osteocalcin, reagent and kit therefor, antihuman osteocalcin antibody, hybridoma producing said antibody, and method of producing said antibody
EP0261493A3 (en) Method for the determination of igm and iga immunoglobulins and reagents therefor
DE3273844D1 (en) Procedure for immunological determinations using two antibodies, the second antibody being purified by affinity chromatography, and supports therefor
AU556178B1 (en) Process and monoclonal antibodies to assay follicle- stimulating hormone
DE3569161D1 (en) Process for assaying atl virus antibody and reagent therefore
ES8609725A1 (en) Method for the determination of a substance capable of immunological binding.
AU2868489A (en) Assays for incipient diabetes, monoclonal antibodies used therein and kits for use therefor
ZA861550B (en) Process and reagent for the determination of the luteinising hormone and monoclonal antibodies suitable therefor
AU6677886A (en) Process and reagent for the immunological determination of testosterone and monoclonal antibodies suitable therefor